Abstract
The aims of this study were firstly to evaluate the pathogenicity of an Italian isolate of the QX strain of infectious bronchitis (IB) virus using 1-day-old female SPF chicks (layer type) and 1-day-old female commercial broiler type chickens and secondly to assess the level of protection induced in these birds by a vaccination programme including the IB Massachusetts and 4/91 serotype live attenuated vaccines.
Unvaccinated birds showed clinical signs of varying severity, predominantly affecting the upper respiratory tract. Vaccinated birds appeared healthy, with the exception of a very mild conjunctivitis affecting a limited number of the broilers.
Vaccination fully protected SPF birds, since no histopathological lesions were observed, nor was virus detected following challenge. In broilers replication of the challenge virus was not prevented but was significantly reduced.
The present study confirms that vaccination at day-old and at 14 days of age using the Ma5 and 4/91 IB vaccines may be instrumental in reducing the economic impact of QX IBV infections in layer and broiler farms. 
Introduction
The Italian poultry industry has observed in recent years an increasing incidence of respiratory pathologies related to infection with infectious bronchitis virus (IBV) (Beato et al., 2005b) . The IB viruses involved may be classified into three groups:
native viruses with a localized incidence in Italy (624/I serotypes) (Capua et al., 1994; ; those that apparently originated in Italy and spread across Europe (IT-02 serotypes) (Jones et al., 2005) ; those that have originated elsewhere and spread across
Italian borders (793B, B1648, CR-84221, Chinese QX-like serotypes) (Beato et al., 2005 a, b) .
Some IB variants however, regardless of where they were first isolated, appear to become predominant in several countries over a certain period of time. This has occurred in the past with the so-called Dutch variants (D1466 and D274) during the 1980s, the UK 793B (4/91; CR88) strain during the early 1990s, the Italian strain (IT-02) at the turn of the century and the QX-like IBV in more recent times. These viruses appear to have become widespread in several countries in Europe, and are causing severe losses to both the layer and broiler industry (Worthington et al., 2004; .
Since 2004 the circulation of a new IBV variant has been reported in China (Liu et al., 2004) . This virus, identified as QX, was associated predominantly with various forms of renal pathology. Following this first report other investigators have described the circulation of similar strains in China (Liu et al., 2005) . Cuiping et al., (2007) confirmed data presented by Liu et al. (2005) (Landman et al., 2005) . The viral strain, later characterized as QX-like, was suspected of causing a high incidence of false layers and was detected in the kidneys and oviduct of challenged SPF and commercial chickens (Landman et al., 2005) . (Beato et al., 2005a) and commercial flocks (Beato et al., 2005b) . The first isolation of a QX related strain in UK, from a Pekin bantam presenting with swollen kidneys at post mortem examination has been reported recently (Gough et al., 2008) .
No information is available currently on the origin and means of introduction of this strain from China to the Western hemisphere (Gough et al., 2008; Bochkov et al., 2006) . In order to explain the very distant geographic locations of this strain, introduction by wild birds has been hypothesized based on the evidence that IBV may replicate in Anseriformes (Bochkov et al., 2008) .
Extensive clinical experience and laboratory studies have shown that vaccination with two or more different live attenuated IBV vaccines confers a broad protection against many important heterologous serotypes (Cook et al., 1999; 2001; Worthington et al., 2006) . This has led to the "protectotype" concept, according to which significant cross-protection can be obtained by using strains which are dominant antigenically. Clinical signs and lesions observed during the outbreak were an increase in mortality rate and nephritis. The challenge virus was isolated from trachea and kidneys of sick and dead broilers in 9 to 11-day-old embryonated SPF chicken eggs. The strain was identified by means of RT-PCR (Adzhar et al., 1996) and sequencing of the amplifier products as described by Keeler et al. (1998) . The isolate showed a high sequence homology (99%) with the S1 amplified fragment of a Chinese strain (QXIBV) associated with nephritis in broilers (Liu & Kong, 2004) . The virus stock for the challenge study was produced by inoculating the field isolates into embryonated SPF chicken eggs via the allantoic cavity and collecting the infectious allantoic fluid 72h post inoculation. The allantoic fluid was clarified by centrifugation at 3000g for 10 The vaccine was dissolved in sterile distilled water (30 ml per 1000 doses) and one drop was applied onto one nostril of each chick in accordance with the manufacturer's instructions.
One bird dose of Nobilis Ma5 contained at least 10 3.5 EID 50. One bird dose of the Nobilis 4/91 vaccine contained 10 3.6 EID 50 .
Experimental design. Four groups of 12 birds each were used in the study; two groups of SPF chickens and two groups of commercial broilers. A negative control group composed of 3 SPF chickens and 3 broilers was also included. Two groups of birds were vaccinated and the other two left unvaccinated. The experimental design used is described below and shown in Table 1 :
• Group 1:12 SPF chicks vaccinated via the nasal route with Nobilis Ma5 at dayold and boosted with Nobilis IB 4/91 at 14 days.
• Group 2: 12 unvaccinated control SPF chicks.
• Group 3: 12 commercial broiler chicks vaccinated via the nasal route with Nobilis Ma5 at day-old and with Nobilis IB 4/91 at 14 days.
• Group 4: 12 unvaccinated control commercial broiler chicks. Prior to challenge, a blood sample was collected from each bird in order to determine the HI antibody titre (Alexander et al., 1983) et al., 1996) with sequencing of the amplified products (Keeler et al., 1998) . HA antigens were prepared from chorioallantoic fluid harvest from IBV-inoculated embryonated SPF eggs and concentrated 100-fold by ultracentrifugation. The concentrated IBV strains were treated with bacterial phospholipase C for 2h at 37°C and used as HA antigens in a microtitre HI test as follows: 4 HA units of antigen was added to two-fold dilutions of serum. After incubation for 30 min at room temperature, a chicken red blood cell Virus detection. The trachea was removed from each bird and a portion fixed in 10% buffered formalin for histological and scanning electron microscope (SEM)
examinations (Robards & Wilson, 1993) , with the remaining part used to attempted virus isolation. For virological examination the tracheal mucosa was scarified with a sterile scalpel blade and transferred into a test tube with 3ml of phosphate buffered saline (PBS) supplemented with antibiotics (10,000 U/mL of penicillin, 10 mg/mL of streptomycin, 0.25 mg/mL of gentamycin and 5,000 U/mL of mycostatin) and 5% of tryptose broth. kidney, ovary and oviduct were also sampled simultaneously and portions fixed in 10% buffered formalin for histological examination. The remaining portions were frozen at -80°C for virus isolation attempts.
To attempt virus isolation from kidney, ovary and oviduct, samples were homogenized with sterile quartz sand, diluted 1:10 with PBS containing antibiotics and left overnight at +4°C before being processed. Samples were inoculated via the allantoic cavity into five, 9 to 11-day-old SPF embryonated hens' eggs with bacteriafree samples. The eggs were candled daily to record embryo mortality. After 7 days, the live embryos were chilled at +4°C and then examined for gross lesions and allantoic fluids harvested for EM examination. Embryo mortality recorded in the first 24 h post inoculation was considered nonspecific. In addition, the allantoic fluid was analyzed by RT-PCR with specific primers for the S1 gene (Adzhar et al., 1996) . The cDNA obtained was sequenced (Keeler et al., 1998) and the isolates typed on the basis of the sequence to confirm the identity of the strains. 
Electron microscopy.
Transmission electron microscopy (TEM). Samples were diluted 10 fold in PBS, frozen and thawed repeatedly and clarified by a two-steps centrifugation (2,500g at 8°C for 30 min and 7,000g at 8°C for 30 min). Next, an aliquot of 85 ml of the supernatant was ultracentrifuged for 15 min in a Beckman Airfuge, using rotor A-100, at 20 psi (125,000g), to pellet the viral particles on formwar carbon coated cupper grids (Doone & Anderson, 1987) . The grids were stained using a 2% sodium phosphotungstate solution in distilled water (pH 6.8) for about 3 min. The dried grids were observed using a TEM Philips operating at 80kV, at 19,000-45,000 x. (Siegel & Castellan, 1992) .
Scanning electron microscopy (SEM

Results
Clinical signs. At 48h after challenge birds of group 4 (unvaccinated broilers), exhibited severe conjunctivitis, mainly of a frothy type, associated with abundant lacrimation, oedema and cellulitis of the periorbital tissues ( Figure 1a) . In addition the birds appeared lethargic, reluctant to move and in some cases presented with dyspnoea. These symptoms regressed progressively in intensity until their disappearance approximately 96h after infection. In group 2 (SPF, unvaccinated), depression, conjunctivitis and periorbital oedema were observed, but in a milder form (Figure 1b) , with complete disappearance of symptoms 72h after challenge. In groups 1 and 3 (SPF and broiler, vaccinated) no clinical signs attributable to IBV infection were observed, with the exception of a very mild conjunctivitis in some broilers which resolved within 48h. Scanning electron microscopy. The SEM examination of tracheas of both nonvaccinated groups (2 and 4) revealed lesions in the respiratory mucosa caused by replication of the challenge virus (Figures 2a and 3a) . This was represented visually by severe erosion of the respiratory epithelium with inflammatory lesions affecting the mucosa. In groups 1 and 3 (vaccinated), no signs of damage or lesions of the trachea were observed (Figures 2b and 3b) . The condition of the respiratory epithelium in these birds was comparable to that of the controls (group 5).
Virus isolation and detection.
The results of the virological examinations are shown in Table 2 . In groups 2 and 4 (non-vaccinated) challenge virus was re-isolated from the tracheas of all birds and RT-PCR and sequence analysis of the re-isolated viruses revealed a 99% homology of the S1 gene with the IBV QX virus. In the same groups, the IBV QX virus was also isolated from kidneys and ovaries/oviducts in almost all the infected birds.
In the vaccinated groups the numbers of infected chickens were lower than in the control groups. No birds were positive in the vaccinated SPF chicks. In the vaccinated broilers, the majority of positive samples were obtained from tracheas (50%) while only in one case was the challenge virus isolated from the urogenital tract (kidney). Table 3 .
Statistical analysis. The analysis of virological results, revealed a significant difference between the number of positive samples among the vaccinates and the nonvaccinates (p < 0.05), which was more evident between the groups of SPF chickens.
The statistical analysis of HI titres showed higher values (p< 0.05) in both SPF and broilers using the vaccine strains (Massachusetts and 4/91 serotypes) as antigens compared to the other antigens. Broilers showed higher HI titres (p<0.05) when sera were tested with the 4/91 antigen than with the M41. This significant difference was not observed for SPF chicken sera. Moreover the HI titres of SPF chickens were higher than those of broiler sera when tested against the vaccine strains (p< 0.05). The results presented herein can be considered as additional evidence that protection against challenge with a heterologous strain of IBV may be achieved by using a vaccination programme containing two live IB vaccine strains that differ antigenically, when administered at an interval of two weeks.
According to the European Pharmacopoeia's reference standards, the test to evaluate IBV vaccine protection is considered valid if the challenge virus is isolated from no less than 80% of the control group. A vaccine is considered effective if the challenge virus is isolated from less than 20% of the animals vaccinated. All of the nonvaccinated birds were infected, based on detection of the virus in tracheas, thus the challenge experiment was successful. Vaccination reduced and, in many cases prevented, replication of the challenge virus in the respiratory tract. As a consequence lesions induced by the IBV QX-like virus in the trachea were absent.
The presence of viable virus in the ovary/oviduct and the kidneys confirms the ability of IBV QX challenge virus to replicate in the female reproductive tract, as well as its nephropathogenic potential (Liu & Kong, 2004; Beato et al, 2005a) . It is likely that this localisation gives rise to local damage that could cause impaired development of the ovary and the oviduct and therefore impact negatively on future laying activity (Landman et al., 2005; Bano et al., 2006) . However in our experiment, no relevant histological lesions were detected in the reproductive tract following IBV QX challenge. The reason for this could be that samples were collected within 6 days after challenge and damage to the ovary and oviduct could take a longer period to develop.
IBV infection of very young layer hens can produce permanent damage to the genital tract that could be evident only several weeks after infection, when the birds come into lay, leading to reduced egg production and quality (Cavanagh & Naqi, 2003) or increasing the incidence of false layers in the flock. The higher susceptibility of vaccinated broiler chicks compared to that recorded in vaccinated SPF chickens could be related to the fact they are offspring of breeders which are immune to IBV as a result of multiple vaccinations. Maternally derived antibodies are known to interfere with IB vaccines administered at day-old (Mondal & Naqi 2001 , Cardoso et al., 2006 . For this reason, particularly under field conditions, it seems reasonable to recommend a double vaccination similar to the one used in our experimental protocol.
In broilers the HI antibody response against the Massachusetts serotype vaccine strain, administered at day-old, was lower (p< 0.05) than the HI antibody response against the 4/91 serotype used for boosting the birds at 14 days of age. By contrast this difference was not observed in SPF chickens. These data show and confirm the interference of the maternal immunity on the response to vaccination performed in one-day-old chicks. On the whole, broiler chicks had lower HI antibody response (p<0.05) to the vaccination compared to SPF chicks.
A medium to low humoral response is in keeping with that expected following the administration of live attenuated IB vaccines. As expected the highest titres were obtained using antigens homologous to vaccine strains. However, birds appeared to be protected against heterologous challenge. The reason for this could be that the presence of local immunity of the upper respiratory tract induced by vaccination reduced the replication of challenge virus after challenge by the oculonasal route.
Furthermore immune responses directed to epitopes involved in protective immunity, might not be fully detected by the HI test.
Despite the low level of genetic homology in the S1 protein between the vaccine and challenge strains, the protection achieved with the vaccination programme used in the present study was high. In fact, the genetic relationship respectively. This confirms previous data (Cook et al., 1999; Worthington et al., 2006) showing that good protection can be achieved by vaccines containing serotypes that differ both antigenically and genetically from the challenge virus. As already proposed, the reason could be that, despite extensive difference in S1 protein, there are epitopes in common among different strains of IBV, which play a major role in protective immunity (Cavanagh et al., 1997) .
Based on data presented in this study it can be concluded that under Reed, L.J. & Muench, H. (1938) . A simple method of estimating fifty percent endpoints.
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